Rugby-based health firm Mediwatch has agreed a deal Down Under.
The medical equipment manufacturer has signed a contract to supply a range of diagnostic urological products to Australian medical devices company Device Technologies.
It reflects the rapidly growing requirement for long-term care of the elderly in Australia and New Zealand.
The five-year sales deal is estimated to be worth in the region of £3 million over the period.
It follows the recent announcement of a two-year sales contract with Accelerated Care Plus worth at least £2 million.
Device Technologies is the largest independent medical device distributor in Australia and New Zealand.
Philip Stimpson, Mediwatch chief executive, said: "I am delighted that Mediwatch has secured this contract with Device Technologies, taking advantage of their expertise.
"This, along with our recent alliance with Accelerated Care Plus, further strengthens the exposure of Mediwatch internationally and reinforces our position as a leading manufacturer of urological diagnostic equipment."
Accurate, reliable and easy-to-use urological diagnostics are considered essential in managing urinary incontinence. Kevin Ryan, Device Technologies managing director, said: "The partnership with Mediwatch will aid better diagnostic and management of incontinence."